Home > Journals > Minerva Cardiology and Angiology > Past Issues > Minerva Cardioangiologica 2012 August;60(4) > Minerva Cardioangiologica 2012 August;60(4):363-73

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

  HEART FAILURE 

Minerva Cardioangiologica 2012 August;60(4):363-73

Copyright © 2012 EDIZIONI MINERVA MEDICA

language: English

Gene and cell therapies for the failing heart to prevent sudden arrhythmic death

Sovari A. A., Dudley S. C. Jr

Section of Cardiology and Center for Cardiovascular Research, University of Illinois at Chicago, Chicago, IL, USA


PDF


Current therapies for treatment and prevention of sudden cardiac death have certain limitations, and a search for new therapeutic approaches is desirable to reduce the burden of sudden arrhythmic death. Gene therapy and stem cell therapy have been investigated as new, valuable tools in treating cardiac diseases such as arrhythmias. In this review, the basics of each modality, important related experimental and clinical studies, and potential advantages and limitations of these treatments will be discussed. The future success of gene and cell therapy to become practical clinical tools greatly depends on our understanding of the mechanisms of ventricular arrhythmia and the mechanisms of action of gene and cell therapy.

top of page